I actually thought we were getting CHF results Qtr 1 2017 ?????
This from the latest company update dated 27th Feb
"An interim analysis of the trial’s primary endpoint is planned for Q1 CY2017."
Thinking the current upward trend in sp was some anticipation of this, but now finding out it was just a pump into CR.....timelines stretch out again.
Last 1/2 yearly showed cash on hand of us56million, plus equity facility for another us90 million, so why another cap comes out as soon as there's any upward momentum.
Is it all just spin in these company updates and they pretty much do anything to full the coffers as soon as opportunity presents, surely another hand dealt from big pharma to get onboard would be whats needed. As usual retail holders get no offer something the company does all the time and any emails to question the practice of no CR offer to holders I have yet to get a response.
Ann: Mesoblast Raises US$40 Million, page-31
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |